Source Citation

Bernard GR, Vincent J-L, Laterre P-F, et al., for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344:699-709. (All 2001 articles were reviewed for relevancy, and abstracts were last revised in 2007.)

Revised Reference (2007)

  • 1 Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. An economic evaluation of activated protein C treatment for severe sepsis. New Engl J Med. 2002;347:993-1000. [PMID: 12324556] Google Scholar